{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "dd4fae54-ae56-4792-9876-fce5f23999b2", "code": "13956-29-1", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=13956-29-1", "code_system": "CAS", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe", "2ce16f7a-920d-452c-9f8f-6ea0334a1440" ] }, { "uuid": "f77589f7-13d1-4983-a648-b34ced5dbd53", "code": "D002185", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68002185", "code_system": "MESH", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "59b2df20-5b1f-4836-b64b-fd186b20df1c", "code": "CANNABIDIOL", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Cannabidiol", "code_system": "WIKIPEDIA", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "560a0404-9142-4ffc-99ec-d5dfbd9c7fac", "code": "C118452", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C118452", "code_system": "NCI_THESAURUS", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "ffb35954-b465-4569-8809-bcbef3f0f058", "code": "m3020", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m3020?q=authorize", "code_system": "MERCK INDEX", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "445f3657-d5ed-486e-8459-7f4433d42804", "code": "SUB26600", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "25916102-f5b6-48f4-a2bd-10469bacfadf", "code": "CHEMBL190461", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "code_system": "ChEMBL", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "abd35d5c-2175-4563-8a3a-97d94caeadd3", "code": "N02BG10", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Other analgesics and antipyretics|cannabinoids", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BG10&showdescription=yes", "code_system": "WHO-ATC", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "e9ea3ce2-f6ed-4b8c-b5a3-e0710e8a1056", "code": "644019", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/644019", "code_system": "PUBCHEM", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "7204f694-cb60-47cd-89ab-18e7c1a91987", "code": "10423", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=10423", "code_system": "INN", "references": [ "2ab2b54c-d285-4ea8-81e0-8964756390fe" ] }, { "uuid": "6ffef968-b183-0beb-a513-e22578b592a8", "code": "452614", "comments": "ORPHAN DRUG|Designated|Treatment of pediatric schizophrenia (pediatrics is defined as 0 through 16 years of age)", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=452614", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "769a2694-d4c2-ec7d-6436-62c2dd690a52", "code": "620417", "comments": "ORPHAN DRUG|Designated|Treatment of glioblastoma multiforme", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=620417", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "60f52644-8705-1213-666b-e9660603ccff", "code": "521416", "comments": "ORPHAN DRUG|Designated|Treatment of infantile spasms", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=521416", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "9c109ccc-27aa-6765-f87c-aa365f18d35a", "code": "545316", "comments": "ORPHAN DRUG|Designated|Treatment of Graft versus Host Disease", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=545316", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "d442c788-97b4-4ec2-ca2b-7faf1ddb6ff6", "code": "498215", "comments": "ORPHAN DRUG|Designated|Treatment of glioma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=498215", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "183a5f2f-90f0-7538-6901-24edca11869b", "code": "471815", "comments": "ORPHAN DRUG|Designated|Treatment of neonatal hypoxic ischemic encephalopathy", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=471815", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "b462de59-fd43-9e00-56bf-a649adcfc1e8", "code": "610117", "comments": "ORPHAN DRUG|Designated|Treatment of Lennox-Gastaut syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=610117", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "60b685b0-fd97-d21d-1743-ec80788c33a3", "code": "617417", "comments": "ORPHAN DRUG|Designated|Treatment of Dravet syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=617417", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "190c9264-1647-df7a-8bbd-e4970bbfbf65", "code": "C274", "comments": "Pharmacologic Substance[C1909]|Antineoplastic Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C274", "code_system": "NCI_THESAURUS", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "222526a8-619d-5e83-db05-a0718c2c2105", "code": "C1742", "comments": "Pharmacologic Substance[C1909]|Antineoplastic Agent[C274]|Angiogenesis Inhibitor", "codeText": "Pharmacologic Substance[C1909]|Antineoplastic Agent[C274]|Angiogenesis Inhibitor", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1742", "code_system": "NCI_THESAURUS", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "b9fea17f-9a7e-a775-9a30-70a3fb689fab", "code": "628818", "comments": "ORPHAN DRUG|Designated|Treatment of amyotrophic lateral sclerosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=628818", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "2415ed1f-b214-2c94-e31d-50f592abe2a5", "code": "444814", "comments": "ORPHAN DRUG|Designated|Treatment of glioblastoma multiforme", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=444814", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "f3b99191-7329-2e8b-48cf-922069d6bbe2", "code": "450814", "comments": "ORPHAN DRUG|Designated|Treatment of glioma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=450814", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "a5050bc7-1fa5-fb4e-a019-b0ef2bcb97a8", "code": "482315", "comments": "ORPHAN DRUG|Designated|Prevention of Graft versus Host Disease (GVHD).", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=482315", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "afb55baf-b984-6098-143e-a9ea4e9a5872", "code": "486115", "comments": "ORPHAN DRUG|Designated|Treatment of infantile spasms", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=486115", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "b5058777-b5b1-75cb-732e-a1b920d0162f", "code": "488315", "comments": "ORPHAN DRUG|Designated|Treatment of Fragile X syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=488315", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "4d81e2b0-7635-0c31-c4e4-249143e412ef", "code": "609617", "comments": "ORPHAN DRUG|Designated|Treatment of autoimmune hepatitis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=609617", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "a591758e-3818-2c88-69e9-003a8153a826", "code": "656618", "comments": "ORPHAN DRUG|Designated|Prevention of ischemia/reperfusion Injury resulting from solid organ transplantation", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=656618", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "f54274b1-e0a0-5248-a965-99e1259ebe65", "code": "C105578", "comments": "Drug or Chemical by Structure[C1913]|Organic Chemical[C718]|Ring Compound[C1933]|Cannabinoid", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C105578", "code_system": "NCI_THESAURUS", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "6c974cda-c75c-4a2a-b998-8c0ca4cb4cc1", "code": "N03AX24", "comments": "ATC|NERVOUS SYSTEM|ANTIEPILEPTICS|ANTIEPILEPTICS|Other antiepileptics|cannabidiol", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N03AX24&showdescription=yes", "code_system": "WHO-ATC", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "d6591018-a543-b2f5-01c8-7f61ca77dd8e", "code": "668918", "comments": "ORPHAN DRUG|Designated|Treatment of Huntington's Disease", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=668918", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "176c1717-b4ce-46a9-be93-ef1e2d31e2d3", "code": "EU/3/17/1959", "comments": "EU ORPHAN DRUG|Positive|Treatment of tuberous sclerosis", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171959", "code_system": "EU-Orphan Drug", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "1010f048-0ad9-abc7-6aec-1a47029b1787", "code": "2045371", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/2045371/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "6b67348a-dd97-ebec-c015-c43f54268cc7" ] }, { "uuid": "d9da647a-3395-4d73-b603-606e2edca695", "code": "19GBJ60SN5", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "2d8ea5a7-e51f-cbd9-f61b-116dd22f9c40", "code": "Cannabidiol", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM1442/", "code_system": "LACTMED", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "c80ca46d-5b42-afd5-243d-8582688c2b8b", "code": "549616", "comments": "ORPHAN DRUG|Designated|Treatment of complex regional pain syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=549616", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "82859cd8-af4a-f83d-9a38-e2c219977d3f", "code": "696519", "comments": "ORPHAN DRUG|Designated|Treatment of childhood absence epilepsy", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "8bf1a68a-053e-38ff-6fb4-882f2d68d421", "code": "734820", "comments": "ORPHAN DRUG|Designated|Treatment of Epidermolysis Bullosa", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=734820", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "d97e9dce-7988-7f6a-d790-6c2da10b00b1", "code": "734620", "comments": "ORPHAN DRUG|Designated|Treatment of Epidermolysis Bullosa", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=734620", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "a85bf6c2-ef95-feca-5fa4-2e56d519a4a1", "code": "736020", "comments": "ORPHAN DRUG|Designated|Treatment of glioblastoma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=736020", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "ab244958-7e39-e1ac-176e-00bd47877836", "code": "538916", "comments": "ORPHAN DRUG|Designated|Treatment of Prader Willi Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=538916", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "5ff2c031-34f0-921d-48e6-aa516409a96d", "code": "3397 (Number of products:162)", "comments": "Dietary Supplement Label Database|chemical|Cannabidiol", "type": "PRIMARY", "url": "https://dsld.od.nih.gov/dsld/rptIngredient.jsp?grpid=3397&item=Cannabidiol", "code_system": "DSLD", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "c78a9727-f3af-48a8-c3a6-153aac0f9b6c", "code": "5288", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/5288", "code_system": "DRUG CENTRAL", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "92c70408-4045-b18c-4c12-755d84f36463", "code": "DB09061", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB09061", "code_system": "DRUG BANK", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "6838ac28-90a5-7d74-6b36-b465f6fe906f", "code": "69478", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:69478", "code_system": "CHEBI", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "a96adf52-e452-f83e-405c-96d62b4f75a5", "code": "819221", "comments": "ORPHAN DRUG|Designated|Treatment of epilepsy with myoclonic-atonic seizures", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=819221", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "ad1eb129-23ee-0573-6fdd-62bf02d1d426", "code": "763820", "comments": "ORPHAN DRUG|Designated|Treatment of 22q.11.2 deletion syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=763820", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "68cd57fa-45c8-0b05-0f63-30255c139501", "code": "1089161", "type": "ALTERNATIVE", "url": "https://store.usp.org/product/1089161", "code_system": "RS_ITEM_NUM", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "95085b18-b23c-b6c5-572a-0bf31759af80", "code": "806620", "comments": "ORPHAN DRUG|Designated|Treatment of Angelman syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=806620", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "dcb8a953-44bc-5373-8fd3-73a820b6f9ab", "code": "860821", "comments": "ORPHAN DRUG|Designated|Treatment of Angelman Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=860821", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "49c91f8a-330d-a900-fb39-cc79d82194c4", "code": "860921", "comments": "ORPHAN DRUG|Designated|Treatment of chromosome 15q11.2-13.1 duplication syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=860921", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "ee8b2f11-05fe-89cf-2df3-df26a4ec1a95", "code": "100000091179", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "21e88422-a4d4-3699-fcef-40a54f183f2e" ] }, { "uuid": "3ba09dcf-44bf-0612-17d6-751846cca665", "code": "CD-48", "type": "PRIMARY", "url": "https://searchusan.ama-assn.org/finder/usan/search/CD-48/relevant/1/", "code_system": "USAN", "references": [ "7f31b32b-0900-351c-88e4-ddf8952eee6b" ] }, { "uuid": "ee5ec9e5-fc1c-7d3b-7fec-50df9ea45b09", "code": "DTXSID00871959", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID00871959", "code_system": "EPA CompTox", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] }, { "uuid": "ab407102-0636-7074-e161-8064c641fd61", "code": "19GBJ60SN5", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=19GBJ60SN5", "code_system": "DAILYMED", "references": [ "987d6c8a-882a-f1d2-ba8c-9a6bfee74971" ] }, { "uuid": "187ac74c-2bce-832d-2a48-634ae5153d49", "code": "510716", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of tuberous sclerosis complex.", "codeText": "ORPHAN DRUG|Designated/Approved|Treatment of tuberous sclerosis complex.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=510716", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "d529fd68-45d0-d548-c00d-7f1924075a21", "code": "438214", "comments": "ORPHAN DRUG|Designated/Withdrawn|Treatment of Lennox-Gastaut syndrome", "codeText": "ORPHAN DRUG|Designated/Withdrawn|Treatment of Lennox-Gastaut syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=438214", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "2bca6eba-8323-d3f3-d73d-fe5855e64c52", "code": "409313", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of Dravet syndrome", "codeText": "ORPHAN DRUG|Designated/Approved|Treatment of Dravet syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=409313", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "b6b7d950-fa93-4a9b-3df2-610652d837c7", "code": "421213", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of Lennox-Gastaut syndrome", "codeText": "ORPHAN DRUG|Designated/Approved|Treatment of Lennox-Gastaut syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=421213", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "2502cefb-9d3a-4c37-a116-979c8bb053ee", "code": "1089149", "type": "PRIMARY", "url": "https://store.usp.org/product/1089149", "code_system": "RS_ITEM_NUM", "references": [ "e779c4d3-c2fa-c1f2-9d7f-e7a1ee20799c" ] }, { "uuid": "a94cca51-6d64-0c77-370a-b62e4bc45d3c", "code": "439414", "comments": "ORPHAN DRUG|Designated/Withdrawn|Treatment of Dravet syndrome", "codeText": "ORPHAN DRUG|Designated/Withdrawn|Treatment of Dravet syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=439414", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "1a8c6d16-f17e-af3c-48f6-9396e0261374", "code": "914322", "comments": "ORPHAN DRUG|Designated|Treatment of Glioblastoma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=914322", "code_system": "FDA ORPHAN DRUG", "references": [ "671be5f0-4c87-5189-ef63-7be33045e241" ] } ], "substance_class": "chemical", "references": [ { "uuid": "55f190bd-a9c1-9da0-0c61-4d2a274a5e29", "citation": "orange book", "doc_type": "ORANGE BOOK", "public_domain": true }, { "uuid": "d3362bf0-2a06-4b69-b8ec-60e8f1d22eb8", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "b269fc11-d05d-4484-bd35-ac1b1c6a29ae", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9068c940-ea2f-4c4d-90fc-a307ecffe264", "citation": "MERCK INDEX", "doc_type": "MERCK INDEX", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "33ba056f-8d4f-4b17-a03b-74296b2bc139", "citation": "MARTINDALE", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "65c6330e-e5c7-423d-8e30-da711bb137c6", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "01b982ad-f8b6-4b72-b34c-acaa84798071", "citation": "PCPC", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fbc5a392-6612-4ea1-aa66-00cf9fdc2676", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f3d943c5-9b99-4dd3-829c-c26a234892ca", "citation": "USAN COUN 2016", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "16207ee7-24d5-48d9-b13c-31ad0020e83f", "citation": "INN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "aa2b0d22-9195-4a7a-8477-5f3fe1b753a5", "citation": "https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751", "url": "https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f4166060-d215-4eb8-9a35-f74c214111a4", "citation": "http://adisinsight.springer.com/drugs/800025601", "url": "http://adisinsight.springer.com/drugs/800025601", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2ab2b54c-d285-4ea8-81e0-8964756390fe", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389646000, "tags": [ "NOMEN" ] }, { "uuid": "1bdb7101-fe4c-4f9c-8193-744c360ea720", "citation": "CHAPTER 2 : CHEMISTRY AND ANALYSIS OF PHYTOCANNABINOIDS AND OTHER CANNABIS CONSTITUENTS BY RUDOLF BRENNEISEN; PAGES 17-49", "url": "http://www.medicinalgenomics.com/wp-content/uploads/2011/12/Chemical-constituents-of-cannabis.pdf", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "74f53656-6d80-4ad4-bd35-29fff7a5b5d0", "citation": "SRS import [19GBJ60SN5]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=19GBJ60SN5", "doc_type": "SRS", "public_domain": true, "document_date": 1493389646000, "tags": [ "NOMEN" ] }, { "uuid": "484c1196-3f95-40ca-a2a5-a4d2f37ee638", "citation": "usan", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4378c3f1-42f6-4ba5-a3e8-53eb4296b694", "citation": "CANNABIDIOL [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e74891ad-381e-418e-a7fc-0d65d0dd328a", "citation": "CANNABIDIOL [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "05df2541-f364-439d-aa6a-265b0f21415c", "citation": "CANNABIDIOL [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "7ba8160c-9a23-4701-ab84-78c7529f0bed", "citation": "CANNABIDIOL [INCI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ae3f1ccd-5de0-4b6b-b279-5d651d2553f1", "citation": "CANNABIDIOL [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "23338e65-fe8d-4363-ab7a-9e970b2077fd", "citation": "CANNABIDIOL [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "21e88422-a4d4-3699-fcef-40a54f183f2e", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "a7a5c43d-980a-25bb-93f5-6e0effb3f3c6", "citation": "Ryberg, E., et al. \"The orphan receptor GPR55 is a novel cannabinoid receptor.\" British journal of pharmacology 152.7 (2007): 1092-1101.", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1038/sj.bjp.0707460", "doc_type": "JA", "public_domain": true }, { "uuid": "9909944a-e867-38f9-8ace-06da5e8e9055", "citation": "https://www.botanixpharma.com/products/", "doc_type": "MANUFACTURER PRODUCT DESCRIPTION", "public_domain": true }, { "uuid": "671be5f0-4c87-5189-ef63-7be33045e241", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "4be53aa9-d7b2-9128-049e-7f64e087edf3", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000SumR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2ce16f7a-920d-452c-9f8f-6ea0334a1440", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ec3e8671-3bdd-861d-835a-b8fba919f689", "citation": "USAN COUN 2016", "doc_type": "USANCOUN", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "85537558-23d3-47dd-b548-fc93434edb08", "citation": "NCT05180240", "url": "https://clinicaltrials.gov/ct2/show/NCT05180240", "doc_type": "CLINICALTRIALS", "public_domain": true }, { "uuid": "ac551717-cb2e-2307-bf16-16ca2cb2973e", "citation": "OB", "doc_type": "ORANGE BOOK", "public_domain": true }, { "uuid": "6b67348a-dd97-ebec-c015-c43f54268cc7", "citation": "RXNORM", "doc_type": "NLM", "public_domain": true }, { "uuid": "444b2614-d68c-4875-9753-a21148b36091", "citation": "INN Proposed List 118", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL118.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7f31b32b-0900-351c-88e4-ddf8952eee6b", "citation": "USAD COUN", "doc_type": "USANCOUN", "public_domain": true }, { "uuid": "b95276f5-fb8f-452d-9ffc-4a258619c041", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000SumR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e779c4d3-c2fa-c1f2-9d7f-e7a1ee20799c", "citation": "USP-RS", "doc_type": "USPNF", "public_domain": true }, { "uuid": "36afd77f-4a5b-4168-95fb-0525032983e3", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "50a70a38-720d-4bed-8e9a-d16d75dd805b", "citation": "Chem Pharm Bull (Tokyo) 1990;38(6):1697", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "987d6c8a-882a-f1d2-ba8c-9a6bfee74971", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "e7d17b86-14d8-40b2-89e0-79a077388af9", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "584af4cc-f88f-63ed-213f-123a022c67e4", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "2e410a92-6b27-44b6-9526-b3bad20abe31", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b38736d3-4623-48e1-be19-0c55c2e50953", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000SumR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4b6872d3-394b-4421-937f-c71977d488be", "citation": "Beers, Jessica L., Dong Fu, and Klarissa D. Jackson. \"Cytochrome P450–catalyzed metabolism of cannabidiol to the active metabolite 7-hydroxy-cannabidiol.\" Drug Metabolism and Disposition 49.10 (2021): 882-891.", "url": "Beers, Jessica L., Dong Fu, and Klarissa D. Jackson. \"Cytochrome P450–catalyzed metabolism of cannabidiol to the active metabolite 7-hydroxy-cannabidiol.\" Drug Metabolism and Disposition 49.10 (2021): 882-891.", "doc_type": "JA", "public_domain": true }, { "uuid": "eccb3c6c-6f06-40f9-b3b4-88992b2c1f60", "citation": "White, C. Michael. \"A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential.\" The Journal of Clinical Pharmacology 59.7 (2019): 923-934.", "url": "White, C. Michael. \"A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential.\" The Journal of Clinical Pharmacology 59.7 (2019): 923-934.", "doc_type": "JA", "public_domain": true }, { "uuid": "f35934b0-959b-4468-bbed-04aff1a274d2", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "4d563707-b13f-4392-82a2-05125490a17a", "id": "4d563707-b13f-4392-82a2-05125490a17a", "molfile": "\n Marvin 10112320162D \n\n 23 24 0 0 1 0 999 V2000\n 0.8125 3.0226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.0946 3.7979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 2.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.0085 3.9980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.4376 1.5230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.9834 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.8665 3.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.5809 3.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.2954 3.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 7.0099 3.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 7.7244 3.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1396 2.1771 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 1.3428 2.3906 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 2.3532 1.3802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7594 1.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.7698 0.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.9729 1.0104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.7230 2.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.7230 3.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.4376 2.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.4374 3.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.1520 2.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.1520 3.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 1 3 2 0 0 0 0\n 13 1 1 1 0 0 0\n 4 19 1 0 0 0 0\n 5 20 1 0 0 0 0\n 6 16 1 0 0 0 0\n 7 8 1 0 0 0 0\n 7 23 1 0 0 0 0\n 8 9 1 0 0 0 0\n 9 10 1 0 0 0 0\n 10 11 1 0 0 0 0\n 12 13 1 0 0 0 0\n 12 14 1 0 0 0 0\n 12 18 1 6 0 0 0\n 13 15 1 0 0 0 0\n 14 16 2 0 0 0 0\n 15 17 1 0 0 0 0\n 16 17 1 0 0 0 0\n 18 19 2 0 0 0 0\n 18 20 1 0 0 0 0\n 19 21 1 0 0 0 0\n 20 22 2 0 0 0 0\n 21 23 2 0 0 0 0\n 22 23 1 0 0 0 0\nM END", "smiles": "CCCCCc1cc(c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(c1)O)O", "formula": "C21H30O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "02751c1c-d3cb-4501-bd42-d31b77419866" }, "defined_stereo": 2, "ez_centers": 0, "molecular_weight": "314.4625", "optical_activity": "UNSPECIFIED", "stereo_centers": 2 } ], "definition_level": "COMPLETE", "uuid": "bd3f6640-1845-472f-b743-c8d77367576f", "version": "206", "structure": { "id": "59942c20-4d61-443a-a60d-7e87859f2ff9", "molfile": "Cannabidiol\n JSDraw210112320162D\n\n 23 24 0 0 1 0 0 V2000\n 19.4012 -5.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.9348 -4.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 17.8649 -6.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.6629 -3.9161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 24.3651 -8.5961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 21.6153 -11.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0670 -3.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.4179 -4.6961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7690 -3.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1201 -4.6961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4711 -3.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9108 -7.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.4040 -6.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.3146 -8.8661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.3009 -8.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.2114 -9.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.7046 -9.5653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 23.0139 -6.2561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 23.0139 -4.6961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.3651 -7.0361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.3649 -3.9161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.7160 -6.2561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.7160 -4.6961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 1 3 2 0 0 0 0\n 13 1 1 1 0 0 0\n 4 19 1 0 0 0 0\n 5 20 1 0 0 0 0\n 6 16 1 0 0 0 0\n 7 8 1 0 0 0 0\n 7 23 1 0 0 0 0\n 8 9 1 0 0 0 0\n 9 10 1 0 0 0 0\n 10 11 1 0 0 0 0\n 12 13 1 0 0 0 0\n 12 14 1 0 0 0 0\n 12 18 1 6 0 0 0\n 13 15 1 0 0 0 0\n 14 16 2 0 0 0 0\n 15 17 1 0 0 0 0\n 16 17 1 0 0 0 0\n 18 19 2 0 0 0 0\n 18 20 1 0 0 0 0\n 19 21 1 0 0 0 0\n 20 22 2 0 0 0 0\n 21 23 2 0 0 0 0\n 22 23 1 0 0 0 0\nM END", "smiles": "CCCCCc1cc(c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(c1)O)O", "formula": "C21H30O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 2, "ez_centers": 0, "molecular_weight": "314.4625", "optical_activity": "UNSPECIFIED", "references": [ "484c1196-3f95-40ca-a2a5-a4d2f37ee638", "74f53656-6d80-4ad4-bd35-29fff7a5b5d0", "444b2614-d68c-4875-9753-a21148b36091" ], "stereo_centers": 2 }, "unii": "19GBJ60SN5", "relationships": [ { "uuid": "ed221e72-151e-4d9e-afdd-774380553b5a", "amount": { "uuid": "39d4a232-7c8c-42f5-9782-885dba710173" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "1e0c111f-e204-46ed-810a-6f915ab76446", "refuuid": "bd3f6640-1845-472f-b743-c8d77367576f", "name": "CANNABIDIOL", "unii": "19GBJ60SN5", "linking_id": "19GBJ60SN5", "ref_pname": "CANNABIDIOL", "substance_class": "reference" } }, { "uuid": "1b64ee4d-1eb6-42a0-90cc-ff997338faa6", "amount": { "uuid": "48f1987a-2ad7-4844-9720-514fc47ed135" }, "comments": "Cannabidiol Class | Anxiolytic Antipsychotic | Analgesic | Anti-inflammatory | Antioxydant | Antispasmodic", "type": "PARENT->ACTIVE CONSTITUENT ALWAYS PRESENT", "references": [ "1bdb7101-fe4c-4f9c-8193-744c360ea720" ], "related_substance": { "uuid": "17b34951-c13d-4390-a1f0-6f421f9970df", "refuuid": "8e61faef-71bb-4cbd-8b70-716ea0fd1d02", "name": "CANNABIS SATIVA SUBSP. INDICA TOP", "unii": "FTS5RM302N", "linking_id": "FTS5RM302N", "ref_pname": "CANNABIS SATIVA SUBSP. INDICA TOP", "substance_class": "reference" } }, { "uuid": "1c9c7241-622e-4e73-bf7f-1e7986abd1f8", "amount": { "uuid": "228fc78b-1d2e-4339-a1c5-c6a4cbb5b005" }, "type": "TARGET->INHIBITOR", "references": [ "a7a5c43d-980a-25bb-93f5-6e0effb3f3c6" ], "related_substance": { "uuid": "a48e0ed6-0ba8-437a-bf5b-80ab27b68f20", "refuuid": "36ac3212-13be-4be7-80d4-d5005082e50b", "name": "G-PROTEIN COUPLED RECEPTOR 55", "unii": "SL5292T581", "linking_id": "SL5292T581", "ref_pname": "G-PROTEIN COUPLED RECEPTOR 55", "substance_class": "reference" } }, { "uuid": "71e4c69f-4e5a-47c3-ae7b-58beea0c079f", "amount": { "uuid": "f4940813-218b-4020-9267-7ffec9fa7109", "units": "%", "low_limit": 94 }, "type": "BINDER->LIGAND", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "792dabc6-e091-4958-a7ac-a750da6426a4", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "78462b8b-c950-4895-b7ba-805a9b747177", "amount": { "uuid": "ff9a00f4-ae2a-4cf9-b835-f0d47572e33d", "average": 50, "units": "%" }, "comments": "The major circulating metabolites include 7-hydroxy-cannabidiol (7-OH-CBD), which was approximately 38% of the parent based on AUC of cannabidiol. ", "type": "METABOLITE ACTIVE->PARENT", "interaction_type": "MAJOR", "mediator_substance": { "uuid": "18550262-8b97-4a6f-aaf2-4ea7f5f27890", "refuuid": "50fbc0e6-a35d-4d72-849b-84bfc9d44cd5", "name": "CYTOCHROME P450 2C9", "unii": "L9DP834D1P", "linking_id": "L9DP834D1P", "ref_pname": "CYTOCHROME P450 2C9", "substance_class": "reference" }, "references": [ "b38736d3-4623-48e1-be19-0c55c2e50953" ], "related_substance": { "uuid": "2302bab3-3847-48a9-b445-a3b98d1efe62", "refuuid": "126d34b2-3e55-4e45-992a-7d5c91c74d56", "name": "7-HYDROXYCANNABIDIOL", "unii": "N38G7JB3K2", "linking_id": "N38G7JB3K2", "ref_pname": "7-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "0b93c8a9-e2e8-48e3-aa4b-ee9fdedc51cd", "amount": { "uuid": "6e87e425-30f4-4b80-9d3e-bf43dc39d6a8" }, "comments": "The major circulating metabolites include 7-carboxy-cannabidiol (7-COOH-CBD), which was approximately 40-fold higher than the parent.", "type": "METABOLITE INACTIVE->PARENT", "interaction_type": "MAJOR", "references": [ "b95276f5-fb8f-452d-9ffc-4a258619c041" ], "related_substance": { "uuid": "e4b5f2ee-50ae-48b2-9ddb-515921da128b", "refuuid": "62f50af4-1825-47af-8b4b-4faa7f128736", "name": "7-CARBOXYCANNABIDIOL", "unii": "9S6E5L3ZXA", "linking_id": "9S6E5L3ZXA", "ref_pname": "7-CARBOXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "1a760c46-9ee9-4062-a24c-ad38f09041b5", "amount": { "uuid": "a3a18d99-61ee-404b-9d11-7ac2f86264bf" }, "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "032c57ff-0804-4b23-beb5-cc5e4e871c91", "refuuid": "29836d3b-873a-4bd7-b376-1ee89a0483ef", "name": "6ALPHA-HYDROXYCANNABIDIOL", "unii": "4JT5NXL2YQ", "linking_id": "4JT5NXL2YQ", "ref_pname": "6ALPHA-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "ddc7880f-77cb-4edd-8ee7-2a84a4d4e451", "amount": { "uuid": "c7ef71d2-8da2-472a-bae7-12be972cd350" }, "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "fcad9d5a-dd27-44ae-b8f5-d63f48607c6e", "refuuid": "7203d379-3e5e-41bb-84e2-50c092397f63", "name": "6.BETA.-HYDROXYCANNABIDIOL", "unii": "8K6W2FVF4P", "linking_id": "8K6W2FVF4P", "ref_pname": "6.BETA.-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "5d46b7d7-0555-40d6-b671-791996b4ceb2", "amount": { "uuid": "267fd610-8562-4ee1-a489-1df2d1941f09" }, "type": "TARGET->ACTIVATOR", "related_substance": { "uuid": "8157da69-4845-4f17-8094-4b0a915063ab", "refuuid": "9bfef87f-df60-4cc3-a78f-4a9ab1339e24", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 1A", "unii": "UKK18ES9TF", "linking_id": "UKK18ES9TF", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 1A", "substance_class": "reference" } }, { "uuid": "feac365e-bf18-4ed8-ba69-d09db8369c10", "amount": { "uuid": "c7063192-47be-4272-a52b-47d20315a632" }, "type": "TARGET->INVERSE AGONIST", "related_substance": { "uuid": "f73cc6a3-4a08-40e2-ab42-67ef2d4359df", "refuuid": "4da43617-82f9-4e30-b375-4d59d4f6fe58", "name": "CANNABINOID RECEPTOR 2", "unii": "SKEU5X23RI", "linking_id": "SKEU5X23RI", "ref_pname": "CANNABINOID RECEPTOR 2", "substance_class": "reference" } }, { "uuid": "04a37c60-683d-4867-9a6f-b280e2d5cba7", "amount": { "uuid": "19a9bd32-27c6-4c61-a764-c010a9713c29" }, "type": "TARGET->INVERSE AGONIST", "related_substance": { "uuid": "22634c42-dab4-4658-898c-46296b1ddbb4", "refuuid": "72b773c6-8217-42c9-82c1-8f9104a414b4", "name": "CANNABINOID RECEPTOR 1", "unii": "NJ1Q2Q7LO5", "linking_id": "NJ1Q2Q7LO5", "ref_pname": "CANNABINOID RECEPTOR 1", "substance_class": "reference" } }, { "uuid": "5541fc26-d807-40fd-965e-dbecc7de5953", "amount": { "uuid": "bf77b425-3f35-4f16-8eb0-019968da3981" }, "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "80397d01-7a91-497f-a39e-c7b43dcc24e1", "refuuid": "8fd03bcd-0cc4-4490-95ce-3a1b2de53ccc", "name": "1''-HYDROXYCANNABIDIOL", "unii": "U45CL3JN5E", "linking_id": "U45CL3JN5E", "ref_pname": "1''-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "0a86ece6-7821-4a13-bd45-bcb932febad2", "amount": { "uuid": "67573f7f-cd0e-471a-a95a-9edf9c1dc88e" }, "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "02a80a4c-0fa5-4dcd-8088-04b77df55770", "refuuid": "d79d48fa-36f1-4bec-a9b4-4a837aac11cf", "name": "2''-HYDROXYCANNABIDIOL", "unii": "7V535ST6LR", "linking_id": "7V535ST6LR", "ref_pname": "2''-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "38b2f0ed-c3c5-4944-ac9b-2fa1f747c41a", "amount": { "uuid": "7efd8da8-5f1c-406e-84c2-799b9836d764" }, "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "e6957c98-b5a3-4eeb-a573-36c71cb1b49c", "refuuid": "4bea38b5-29bc-43ba-bdcf-4486b0d2be1f", "name": "3''-HYDROXYCANNABIDIOL", "unii": "MA2QL6L4DH", "linking_id": "MA2QL6L4DH", "ref_pname": "3''-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "9af95f21-9abb-4d14-bbf5-cad82d0ad0c7", "amount": { "uuid": "0e767ed4-ebc4-44dd-ae03-2039c7bf85ea" }, "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "725092c6-8e93-42ae-ac3a-d9e0c633ae9a", "refuuid": "436eb041-618d-4a5c-82b4-aff4770bd261", "name": "4''-HYDROXYCANNABIDIOL", "unii": "WA854NP548", "linking_id": "WA854NP548", "ref_pname": "4''-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "2cfeede1-17e9-439d-a63f-b57114045067", "amount": { "uuid": "35a2b899-e064-479b-b425-5ceb69aa081f" }, "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "65b14d04-a545-41c2-92f2-f91eb76e28e1", "refuuid": "29df76da-cd75-4b85-847c-fa7d18f7b370", "name": "5''-HYDROXYCANNABIDIOL", "unii": "6NKR82GEW4", "linking_id": "6NKR82GEW4", "ref_pname": "5''-HYDROXYCANNABIDIOL", "substance_class": "reference" } }, { "uuid": "bf27b920-9b27-4bc6-be4e-92516af1b7e9", "amount": { "uuid": "1e69f4b4-9f02-4224-a72d-7b13e178f4c7" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "696e414f-f2a2-4ab4-8dec-8d14cbfafc75", "refuuid": "4f746c19-0e0a-447a-beda-d28b91d6f23e", "name": "CYTOCHROME P450 2C19", "unii": "081I12ZA58", "linking_id": "081I12ZA58", "ref_pname": "CYTOCHROME P450 2C19", "substance_class": "reference" } }, { "uuid": "7133ecb6-04f8-4f49-96db-e5b6f8240b71", "amount": { "uuid": "de152777-de16-4968-bd6b-65005bd9eb53" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "1daa8d58-6018-4622-a5d4-ced60ba9ebe7", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" } }, { "uuid": "18638196-82fb-4443-81cc-314e472a6943", "amount": { "uuid": "72086213-719c-44fb-b60a-1f3585287eff" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "e43aa10d-a144-4144-9a85-e0d5ba0d1dda", "refuuid": "8fd7384c-a8e2-4966-8b13-f0b07113750a", "name": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A7", "unii": "HWT82Q8F2V", "linking_id": "HWT82Q8F2V", "ref_pname": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A7", "substance_class": "reference" } }, { "uuid": "5d6bce5d-cde2-46e8-a817-df683dd58633", "amount": { "uuid": "69c030cb-5cfb-44b3-ad1f-2dafde411d60" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "8e7d6983-6953-4dd9-9ae2-13174b0bff5e", "refuuid": "e6ed39b1-ec4e-4b3d-a3cd-a4305d4187f4", "name": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A9", "unii": "3318TFY23Q", "linking_id": "3318TFY23Q", "ref_pname": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A9", "substance_class": "reference" } }, { "uuid": "6a6eb1c5-00a4-442a-a4a4-9c8ede2f4c89", "amount": { "uuid": "8bfc97d4-ec12-4166-a8c9-1f7a8e7fb921" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ], "related_substance": { "uuid": "4e167943-7615-4400-88df-e0cf1f9045a9", "refuuid": "e720bbda-7ff3-4519-9e1c-8a4880de5e0f", "name": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B7", "unii": "0M77ZW789J", "linking_id": "0M77ZW789J", "ref_pname": "URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B7", "substance_class": "reference" } }, { "uuid": "4817d78d-509d-48ac-9182-82357cc3e312", "amount": { "uuid": "28934f73-a674-4c06-8d86-ae7ac3852e20" }, "type": "METABOLITE->PARENT", "references": [ "50a70a38-720d-4bed-8e9a-d16d75dd805b" ], "related_substance": { "uuid": "338ba800-184b-4619-a807-f70bda795123", "refuuid": "2d54b59a-b315-4a05-b080-d71c62f82f13", "name": "CANNABIDIOL DIMETHYL ETHER", "unii": "MK7IHZ7MIM", "linking_id": "MK7IHZ7MIM", "ref_pname": "CANNABIDIOL DIMETHYL ETHER" } }, { "uuid": "b4d8ca09-966c-464c-8457-1008b2aa9c64", "amount": { "uuid": "7477c8df-e10d-4cf3-b820-2356f3a9f63d" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4b6872d3-394b-4421-937f-c71977d488be" ], "related_substance": { "uuid": "4003803b-53c7-4d2e-85bf-02b78c5c9194", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" } }, { "uuid": "78de1dfe-1f75-4dde-b82e-8c2bce7985bd", "amount": { "uuid": "06c085af-97b9-4d14-a0fc-e8c3498b057f" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "4b6872d3-394b-4421-937f-c71977d488be" ], "related_substance": { "uuid": "e6b166c0-ea18-4993-9654-9e292100fb09", "refuuid": "50fbc0e6-a35d-4d72-849b-84bfc9d44cd5", "name": "CYTOCHROME P450 2C9", "unii": "L9DP834D1P", "linking_id": "L9DP834D1P", "ref_pname": "CYTOCHROME P450 2C9", "substance_class": "reference" } }, { "uuid": "afa6ecf5-2cf7-4df5-9550-ec46f8e5ae7d", "amount": { "uuid": "cb0cea8b-ea55-41d9-88dd-83bade9314c1" }, "comments": "Responsible for a drug interaction with clobazam. Mean increase in clozabam and N-desmethylclozabam levels was 60% and 500%, respectively, after 4 weeks of concomitant therapy. ", "type": "METABOLIC ENZYME->INHIBITOR", "references": [ "eccb3c6c-6f06-40f9-b3b4-88992b2c1f60" ], "related_substance": { "uuid": "92091f36-542e-40b4-adb8-e9fd9b5b11af", "refuuid": "4f746c19-0e0a-447a-beda-d28b91d6f23e", "name": "CYTOCHROME P450 2C19", "unii": "081I12ZA58", "linking_id": "081I12ZA58", "ref_pname": "CYTOCHROME P450 2C19", "substance_class": "reference" } } ], "names": [ { "uuid": "28fd4656-5caa-7ecc-6193-36063be68bd9", "name": "(-)-CANNABIDIOL", "stdName": "(-)-CANNABIDIOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2ce16f7a-920d-452c-9f8f-6ea0334a1440" ], "display_name": false }, { "uuid": "8ee468ab-0540-d406-6fb5-ca1516e6556d", "name": "(-)-CBD", "stdName": "(-)-CBD", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2ce16f7a-920d-452c-9f8f-6ea0334a1440" ], "display_name": false }, { "uuid": "f33403de-f110-8dd5-5370-44ae6d839359", "name": "(-)-TRANS-CANNABIDIOL", "stdName": "(-)-TRANS-CANNABIDIOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2ce16f7a-920d-452c-9f8f-6ea0334a1440" ], "display_name": false }, { "uuid": "160ed89f-2e5f-4d2b-8fd8-40d5f6f5da32", "name": ".DELTA.1(2)-TRANS-CANNABIDIOL", "stdName": ".DELTA.1(2)-TRANS-CANNABIDIOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "fbc5a392-6612-4ea1-aa66-00cf9fdc2676" ], "display_name": false }, { "uuid": "a9685e59-011d-4cef-9aea-523e47f710bc", "name": "1,3-BENZENEDIOL, 2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-", "stdName": "1,3-BENZENEDIOL, 2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "d3362bf0-2a06-4b69-b8ec-60e8f1d22eb8" ], "display_name": false }, { "uuid": "6f6e4b81-cfbd-442b-b59c-c48358de5e4e", "name": "2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-2-ENYL)-5-PENTYLBENZENE-1,3-DIOL", "stdName": "2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-2-ENYL)-5-PENTYLBENZENE-1,3-DIOL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "d3362bf0-2a06-4b69-b8ec-60e8f1d22eb8" ], "display_name": false }, { "uuid": "65a97a98-9d1f-4143-bf99-6b70934dbaca", "name": "2-((1R,6R)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-2-EN-1-YL)-5-PENTYLBENZENE-1,3-DIOL", "stdName": "2-((1R,6R)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-2-EN-1-YL)-5-PENTYLBENZENE-1,3-DIOL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "16207ee7-24d5-48d9-b13c-31ad0020e83f", "9068c940-ea2f-4c4d-90fc-a307ecffe264" ], "display_name": false }, { "uuid": "9f9cde70-dc77-4790-87eb-36103af3f405", "name": "BTX-1204", "stdName": "BTX-1204", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9909944a-e867-38f9-8ace-06da5e8e9055" ], "display_name": false }, { "uuid": "88fbae7d-e366-102e-a33f-9e3edab72a9a", "name": "BTX-1503", "stdName": "BTX-1503", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9909944a-e867-38f9-8ace-06da5e8e9055" ], "display_name": false }, { "uuid": "d0d79f96-fe75-4bb3-96e3-40c3eb117646", "name": "CANNABIDIOL", "stdName": "CANNABIDIOL", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "01b982ad-f8b6-4b72-b34c-acaa84798071", "05df2541-f364-439d-aa6a-265b0f21415c", "7ba8160c-9a23-4701-ab84-78c7529f0bed", "f3d943c5-9b99-4dd3-829c-c26a234892ca", "23338e65-fe8d-4363-ab7a-9e970b2077fd", "ae3f1ccd-5de0-4b6b-b279-5d651d2553f1", "e74891ad-381e-418e-a7fc-0d65d0dd328a", "65c6330e-e5c7-423d-8e30-da711bb137c6", "9068c940-ea2f-4c4d-90fc-a307ecffe264", "4378c3f1-42f6-4ba5-a3e8-53eb4296b694", "16207ee7-24d5-48d9-b13c-31ad0020e83f", "b269fc11-d05d-4484-bd35-ac1b1c6a29ae", "33ba056f-8d4f-4b17-a03b-74296b2bc139", "d3362bf0-2a06-4b69-b8ec-60e8f1d22eb8" ], "display_name": true, "domains": [ "drug", "cosmetic" ], "name_orgs": [ { "uuid": "fb73b98d-927b-4ab2-9caf-62c945597f42", "name_org": "INCI" }, { "uuid": "c514a82d-65d0-43aa-8c53-8fa25d04818b", "name_org": "INN" }, { "uuid": "2f1cf303-9990-4421-ae1d-1bdf21ca4e14", "name_org": "USAN" } ] }, { "uuid": "bd965477-9e78-171b-c87d-6cc2603e11b3", "name": "CANNABIDIOL SOLUTION [USP-RS]", "stdName": "CANNABIDIOL SOLUTION [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e779c4d3-c2fa-c1f2-9d7f-e7a1ee20799c" ], "display_name": false }, { "uuid": "3f531479-fefa-4431-9389-6a57b7b39f01", "name": "CANNABIDIOL [MART.]", "stdName": "CANNABIDIOL [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "33ba056f-8d4f-4b17-a03b-74296b2bc139" ], "display_name": false }, { "uuid": "96365a76-5262-4cc9-a772-b648c4c756d8", "name": "CANNABIDIOL [MI]", "stdName": "CANNABIDIOL [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "b269fc11-d05d-4484-bd35-ac1b1c6a29ae" ], "display_name": false }, { "uuid": "a12ecc44-4301-af40-8c93-290a74b81521", "name": "CANNABIDIOL [ORANGE BOOK]", "stdName": "CANNABIDIOL [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ac551717-cb2e-2307-bf16-16ca2cb2973e" ], "display_name": false }, { "uuid": "00c9eac7-9770-4aaf-9473-a692879c3db9", "name": "CANNABIDIOL [USAN]", "stdName": "CANNABIDIOL [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "f3d943c5-9b99-4dd3-829c-c26a234892ca" ], "display_name": false }, { "uuid": "0d55e63b-102c-228c-c76c-c6df40aff036", "name": "CANNABIDIOL [USP-RS]", "stdName": "CANNABIDIOL [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e779c4d3-c2fa-c1f2-9d7f-e7a1ee20799c" ], "display_name": false }, { "uuid": "435b6ae5-eac6-48e0-a8c9-bfc3bdbe6853", "name": "CARDIOLRX", "stdName": "CARDIOLRX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "85537558-23d3-47dd-b548-fc93434edb08" ], "display_name": false }, { "uuid": "9a804b17-4f96-46a9-9634-6b56cd788b3f", "name": "CBD", "stdName": "CBD", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d3362bf0-2a06-4b69-b8ec-60e8f1d22eb8" ], "display_name": false }, { "uuid": "20e1db6c-b40e-ad52-5386-6e0308ffcef5", "name": "Cannabidiol [WHO-DD]", "stdName": "CANNABIDIOL [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "584af4cc-f88f-63ed-213f-123a022c67e4" ], "display_name": false }, { "uuid": "3b55a659-a23e-4c75-821c-28f451e572a5", "name": "EPIDIOLEX", "stdName": "EPIDIOLEX", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "aa2b0d22-9195-4a7a-8477-5f3fe1b753a5", "9068c940-ea2f-4c4d-90fc-a307ecffe264" ], "display_name": false }, { "uuid": "8fd8a406-19af-4c2e-95bd-5c3c02c19e74", "name": "GWP-42003", "stdName": "GWP-42003", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "f4166060-d215-4eb8-9a35-f74c214111a4" ], "display_name": false }, { "uuid": "c7ce7c00-6ede-4749-852d-f79a095dbeb1", "name": "GWP-42003-P", "stdName": "GWP-42003-P", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "f3d943c5-9b99-4dd3-829c-c26a234892ca" ], "display_name": false }, { "uuid": "ec06bcc1-9a58-4645-83c6-d743ba60c8c7", "name": "GWP42003", "stdName": "GWP42003", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "f4166060-d215-4eb8-9a35-f74c214111a4" ], "display_name": false }, { "uuid": "fd48ad80-233b-4d2f-8d16-bfb5b477a017", "name": "GWP42003-P", "stdName": "GWP42003-P", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "9068c940-ea2f-4c4d-90fc-a307ecffe264", "f3d943c5-9b99-4dd3-829c-c26a234892ca" ], "display_name": false }, { "uuid": "da2ed7a2-5d64-488a-bbc2-c13f2a62c76c", "name": "cannabidiol [INN]", "stdName": "CANNABIDIOL [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "16207ee7-24d5-48d9-b13c-31ad0020e83f", "9068c940-ea2f-4c4d-90fc-a307ecffe264", "444b2614-d68c-4875-9753-a21148b36091" ], "display_name": false } ], "properties": [ { "uuid": "26740903-e68e-485e-b7fb-cecb76d55a81", "name": "Tmax", "value": { "uuid": "11a7dbb5-a8ac-43a6-bac2-48cd555bd036", "high": 5, "low": 2.5, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ] }, { "uuid": "a0ea4203-c2eb-4196-a590-13216f668241", "name": "Volume of Distribution", "value": { "uuid": "6016760d-f6b6-47de-bafc-4be9eb8a6b61", "high": 42849, "low": 20963, "units": "LITERS" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ] }, { "uuid": "affed7df-366e-44bb-9097-3ab2b0aa3cf1", "name": "Biological Half-life", "value": { "uuid": "7b79f324-c231-4581-9201-3bf4c97ffa17", "high": 61, "low": 56, "units": "hours" }, "defining": false, "parameters": [ { "uuid": "a7d5828e-363e-42cb-ad73-5bcc858018b4", "name": "TWICE-DAILY DOSING FOR 7 DAYS", "references": [] } ], "property_type": "PHARMACOKINETIC", "references": [ "4be53aa9-d7b2-9128-049e-7f64e087edf3" ] } ], "modifications": { "uuid": "7b9e80aa-d327-4b1b-966e-0ec4a9f255e4" } } ] }